Maxamine fails to convince ODAC as treatment for advanced metastatic melanoma Dec. 15, 2000 No Comments
Herceptin enters phase III trial as adjuvant therapy in early-stage breast cancer Dec. 13, 2000 No Comments
IL-2 variant with T-cell selectivity displays antitumor activity and good tolerance in animals Dec. 12, 2000 No Comments
Efficacy/safety of Campath-1H in acute and chronic leukemias reported at ASH meeting Dec. 12, 2000 No Comments
Final analysis of phase I results for BrevaRex presented to American Society of Hematology Dec. 7, 2000 No Comments
Antigenics expands pancreatic cancer phase I/II trial following positive data with Oncophage vaccine Dec. 6, 2000 No Comments
RSS